Comparing standard- and low-dose CBCT in diagnosis and treatment decisions for impacted mandibular third molars: a non-inferiority randomised clinical study.

Clin Oral Investig · 2024 · PMC11573800 · PMID 39557798

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might not be significantno p-value reported

Nevertheless, due to the comparable mAs values of low-dose protocols 2 and 3, the impact of mAs difference on the MC visibility might not be significant.

also in 673 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.